Participate in a Study - ALBUQUERQUE NEUROSCIENCE

Current Studies

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

For participants ages 18 to 45 experiencing Postpartum Depression.
Gave birth within the last 6 months.
Depression symptoms began at some point between the third trimester and 4 weeks after delivery.
Willing to consider alternatives to breastfeeding while taking study medication (3 weeks).

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

For participants ages 18 to 50
Diagnosis of schizophrenia.
Symptoms and treatments have been generally stable for the last 3 months.
Have a study partner who can participate in the study also.

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (Vibrant)

For participants ages 22 and older
On average have between 1 and 3 spontaneous (with out laxative) bowel movements a week.

Study in Major Depressive Disorder With BTRX-335140 vs Placebo

For participants ages 25 to 65
Have Major Depressive Disorder with decreased ability to enjoy usual activities.
Study participation is approximately 3 months long with visits every two weeks.

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

For participants ages 55 to 80
Have Mild to Moderate Alzheimer's Disease
Have a Study Partner or Caregiver who can attend study visit

A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder

Are 18 - 75 years of age
Have had symptoms of Major Depression for at least 4 weeks
This study involves taking a study medication for 2 weeks and then follow up for 12 months.